Arkolith/Insider Trading/NVCT/Form 4

Mosseri Marlio Charles

10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4 · filed Jun 20, 2025
Net Buying
Open-Market Buys
$270K
Open-Market Sells
$0
Net Open-Market Flow
$270K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2025Buy(P)28K$8.05$226K3.0M
Jun 17, 2025Buy(P)5K$8.11$44K2.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-060965) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML